Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Ageing Research Reviews|February 22, 2023
Sinus node dysfunction and atrial fibrillation-Relationships, clinical phenotypes, new mechanisms, and treatment approachesSuhang Duan, Jianlin Du
Experimental Cell Research|June 12, 2021
Tbx18-positive cells-derived myofibroblasts contribute to renal interstitial fibrosis via transforming growth factor-β signalingXin Yuan, Ling Zhang, Jianlin Du
Computational and Structural Biotechnology Journal|May 14, 2023
Single-cell and spatial transcriptomics: Advances in heart development and disease applicationsXianglin Long, Xin Yuan, Jianlin Du
Archives of Pharmacal Research|February 2, 2023
Dapagliflozin attenuates myocardial remodeling in hypertension by activating the circadian rhythm signaling pathwayJing Wang, Qiang She, Jianlin Du
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 12, 2023
RNA-Seq transcriptomic landscape profiling of spontaneously hypertensive rats treated with a sodium-glucose cotransporter 2 (SGLT2) inhibitorFangyan Tan, Xianglin Long, Jianlin Du, et al.
American Journal of Hypertension|July 28, 2025
Effect of sacubitril-valsartan on transcriptomic changes in lung tissue of spontaneously hypertensive rats: a multi-omics study based on RNA-Seq transcriptome analysisZhengxiang Lv, Weiran Dai, Shunkang Rong, et al.
International Journal of Cardiology|December 4, 2016
Defining the role of perioperative statin treatment in patients after cardiac surgery: A meta-analysis and systematic review of 20 randomized controlled trialsXin Yuan, Jianlin Du, Qi Liu, et al.
Inflammation|May 11, 2026
Identification of ATF3 as a Potential Key Biomarker for Hypertensive Nephropathy via Single-Cell Transcriptome SequencingFangyan Tan, Rong Hu, Jianlin Du, et al.
Journal of Cardiovascular Pharmacology|November 2, 2020
Agrin Yes-associated Protein Promotes the Proliferation of Epicardial CellsXiaodong Jing, Bin Liu, Songbai Deng, et al.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|May 10, 2020
[Effect of proprotein convertase subtilisin/kexin type 9 inhibitor on blood lipid profile in patients with extremely high risk atherosclerotic cardiovascular disease]Jing Wang, Songbai Deng, Yajie Liu, et al.
Pageof 5